French drug-maker Sanofi is looking to re-establish itself in the Indian re-usable insulin pen market with its new “Allstarâ€. While Sanofi is betting on an aggressive pricing strategy to drive sales, it faces an uphill task, reports Archana Shukla of CNBC-TV18.